The earnings call indicates a positive trajectory with strong revenue and income growth, driven by key products like AirSeal, Buffalo Filter, and BioBrace. However, there are challenges in the orthopedic market share and the impact of tariffs, suggesting a balanced outlook.

Company Guidance

During the CONMED Second Quarter Fiscal 2025 Earnings Conference Call, management discussed several key financial metrics and growth projections. Total sales for the quarter were reported at $342.3 million, reflecting a year-over-year growth of 3.1% as reported and 2.9% in constant currency. The company highlighted a 4.4% increase in worldwide general surgery sales and a 0.8% growth in worldwide orthopedic sales. Adjusted net income rose by 16.4% year-over-year to $35.6 million, with adjusted diluted net earnings per share increasing by 17.3% to $1.15. CONMED projected a mid to high single-digit revenue growth in the long term, supported by its key growth drivers: AirSeal, Buffalo Filter, BioBrace, and Foot & Ankle. The AirSeal platform is expected to grow in the high single digits to low double digits annually. Additionally, Buffalo Filter continued to show double-digit growth, and BioBrace experienced strong demand across 52 distinct procedures. The company also emphasized its commitment to overcoming supply chain challenges and reducing its leverage ratio to below 3.0 by the end of 2025, thereby enhancing financial flexibility for future investments.

Strong Revenue Growth

Total sales for Q2 2025 were $342.3 million, slightly above the high end of guidance with a year-over-year growth of 3.1% as reported and 2.9% in constant currency.

Significant Increase in Adjusted Net Income

Adjusted net income for Q2 2025 was $35.6 million, representing a 16.4% increase year-over-year.

AirSeal Platform Growth

AirSeal is used in 35% to 40% of Xi procedures and projects high single-digit to low double-digit growth annually over the next five years.

Buffalo Filter's Double-Digit Growth

Buffalo Filter achieved another quarter of double-digit growth supported by legislative adoption and new product introductions.

BioBrace Driving Orthopedic Growth

BioBrace demonstrated double-digit demand and is now used in 52 distinct procedures, with FDA clearance of a dedicated surgery device for rotator cuff repair.

Foot & Ankle Products Continue Momentum

Foot & Ankle products reported double-digit growth for the third consecutive quarter due to successful resolution of prior supply chain challenges.

Conmed (CNMD) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

CNMD Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 22, 2025	2025 (Q3)	1.05 / -	1.05	―	―	―
Jul 30, 2025	2025 (Q2)	1.12 / 1.15	0.98	17.35% (+0.17)
Apr 30, 2025	2025 (Q1)	0.81 / 0.95	0.79	20.25% (+0.16)
Feb 05, 2025	2024 (Q4)	1.20 / 1.34	1.06	26.42% (+0.28)
Oct 30, 2024	2024 (Q3)	1.02 / 1.05	0.9	16.67% (+0.15)
Jul 31, 2024	2024 (Q2)	0.91 / 0.98	0.83	18.07% (+0.15)
Apr 24, 2024	2024 (Q1)	0.74 / 0.79	0.66	19.70% (+0.13)
Jan 31, 2024	2023 (Q4)	1.11 / 1.06	0.42	152.38% (+0.64)
Oct 25, 2023	2023 (Q3)	0.84 / 0.90	0.77	16.88% (+0.13)
Jul 26, 2023	2023 (Q2)	0.79 / 0.83	0.76	9.21% (+0.07)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

CNMD Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 30, 2025	$50.14	$51.15	+2.01%
Apr 30, 2025	$48.93	$56.98	+16.45%
Feb 05, 2025	$73.48	$66.88	-8.98%
Oct 30, 2024	$64.62	$67.56	+4.55%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Conmed (CNMD) report earnings?

Conmed (CNMD) is schdueled to report earning on Oct 22, 2025, After Close (Confirmed).

What is Conmed (CNMD) earnings time?

Conmed (CNMD) earnings time is at Oct 22, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is CNMD EPS forecast?

CNMD EPS forecast for the fiscal quarter 2025 (Q3) is 1.05.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing